Lehman Financial Resources’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q3
$245K Buy
3,949
+192
+5% +$11.4K 0.11% 81
2018
Q2
$207K Buy
+3,757
New +$203K 0.1% 78
2015
Q4
Sell
-2,315
Closed -$137K 94
2015
Q3
$137K Hold
2,315
0.07% 70
2015
Q2
$154K Hold
2,315
0.07% 69
2015
Q1
$149K Hold
2,315
0.07% 75
2014
Q4
$137K Buy
2,315
+1,500
+184% +$84.6K 0.07% 79
2014
Q3
$42K Hold
815
0.02% 165
2014
Q2
$40K Hold
815
0.02% 165
2014
Q1
$42K Hold
815
0.02% 152
2013
Q4
$43K Hold
815
0.03% 143
2013
Q3
$38K Hold
815
0.02% 139
2013
Q2
$36K Buy
+815
New +$35.4K 0.02% 121

Other funds holding BMY

Lehman Financial Resources's BMY Position: Q3 2018 in Review

Lehman Financial Resources increased its Bristol-Myers Squibb (BMY) stake by 5.1% in Q3 2018, buying an estimated $11.4K and bringing the position to 3,949 shares worth $245K. The position accounts for 0.11% of the portfolio, ranked #81.

Lehman Financial Resources first reported a position in BMY in Q2 2013 and has held it in 12 quarters since. 1,729 funds tracked by Wall St. Rank hold BMY as of Q3 2018.

  • Lehman Financial Resources held 3,949 shares of Bristol-Myers Squibb worth $245K as of Q3 2018.
  • Lehman Financial Resources bought 192 Bristol-Myers Squibb shares in Q3 2018, an estimated $11.4K.
  • Bristol-Myers Squibb made up 0.11% of Lehman Financial Resources's portfolio in Q3 2018, its #81 holding.
  • Lehman Financial Resources first reported a position in Bristol-Myers Squibb in Q2 2013 and has held it in 12 quarters since.
  • 1,729 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2018.

Based on Lehman Financial Resources's 13F filing for Q3 2018, filed 14 Nov 2018.